【期刊速览】Journal of Neurosurgery | Online 2024年10月速览(一)

学术   2024-11-25 18:51   上海  
以下由机器智能翻译,仅供参考。





1. Association between accumulation of 2-hydroxyglutarate detected by MR spectroscopy and preoperative seizure in IDH-mutant glioma

IDH突变型神经胶质瘤中MR光谱检测到的2-羟基戊二酸的积累与术前癫痫发作之间的关联


Researchers used 3T magnetic resonance spectroscopy (MRS) to determine whether accumulation of 2-hydroxyglutaric acid (2HG) is indicative of preoperative seizures in glioma. This study showed that elevated 2HG levels on MRS may be associated with preoperative seizures, suggesting that 2HG accumulation increases the risk of preoperative seizures in IDH-mutant gliomas. Thus, this study provides a strong preclinical rationale for predicting preoperative epilepsy using clinical setting 2HG-MRS in patients with IDH-mutant gliomas.

研究人员使用3t磁共振波谱 (MRS) 来确定2-羟基戊二酸 (2HG) 的积累是否指示神经胶质瘤的术前癫痫发作。这项研究表明,MRS上的2HG水平升高可能与术前癫痫发作有关,这表明2HG积累会增加IDH突变型神经胶质瘤术前癫痫发作的风险。因此,这项研究为IDH突变神经胶质瘤患者使用临床设置2HG-MRS预测术前癫痫提供了强有力的临床前理论基础。
REF: Nagashima H, Tanaka K, Yamanishi S, et al. Association between accumulation of 2-hydroxyglutarate detected by MR spectroscopy and preoperative seizure in IDH-mutant glioma. J Neurosurg. Published online October 25, 2024. doi:10.3171/2024.6.JNS24166 PMID: 39454209











2. Effects of paroxetine, a P2X4 inhibitor, on cerebral aneurysm growth and recanalization after coil embolization: the NHO Drug for Aneurysm Study
P2X4抑制剂帕罗西汀对弹簧圈栓塞后脑动脉瘤生长和再通的影响:NHO动脉瘤药物研究


The purpose of the study was to determine whether oral administration of paroxetine, an inhibitor of P2X4, by which vascular endothelial cells sense blood flow, prevents cerebral aneurysm growth and recanalization after coil embolization. In a historical cohort study, paroxetine significantly prevented both cerebral aneurysm growth and recanalization in the year after coiling. P2X4 inhibitors, including paroxetine, may be clinically applicable as prophylaxis against both aneurysm rupture and recurrence after coil embolization.

该研究的目的是确定口服帕罗西汀 (一种P2X4抑制剂) 是否可以防止弹簧圈栓塞后脑动脉瘤的生长和再通。在一项历史性队列研究中,帕罗西汀在弹簧圈栓塞后的一年中显着阻止了脑动脉瘤的生长和再通。P2X4抑制剂,包括帕罗西汀,可在临床上用于预防动脉瘤破裂和弹簧圈栓塞后的复发。

REF: Fukuda S, Niwa Y, Ren N, et al. Effects of paroxetine, a P2X4 inhibitor, on cerebral aneurysm growth and recanalization after coil embolization: the NHO Drug for Aneurysm Study. J Neurosurg. Published online October 25, 2024. doi:10.3171/2024.6.JNS24714 PMID: 39454214












3. Endoscopic transorbital approach for resection of mediobasal temporal lesions using an optic radiation–sparing strategy
内窥镜经眶入路使用光学辐射保留策略切除颞内侧病变


This study evaluated the feasibility of an optic radiation (OR)-sparing surgical strategy using the endoscopic transorbital approach for treating lesions involving the mediobasal temporal region, with the application of OR tractography to ensure preservation of the visual pathway during and after surgery. The approach enabled gross-total resection in most patients without surgical complications, and postoperative neuro-ophthalmological examinations showed intact or stable visual function in all patients. Follow-up diffusion tensor imaging tractography confirmed the preservation of the optic tracts, indicating that the approach minimizes the risk of visual dysfunction.

这项研究评估了使用内窥镜经眶入路治疗累及中底颞部区域的病变的光学辐射 (OR) 保留手术策略的可行性,并应用OR纤维束成像以确保在手术期间和手术后保留视觉通路。该方法可使大多数患者全部切除而无手术并发症,术后神经眼科检查显示所有患者的视功能均完整或稳定。后续的扩散张量成像纤维束成像证实了视神经管的保留,表明该方法可最大程度地降低视觉功能障碍的风险。

REF: Jeon C, Hong CK, Chong K, et al. Endoscopic transorbital approach for resection of mediobasal temporal lesions using an optic radiation-sparing strategy. J Neurosurg. Published online October 25, 2024. doi:10.3171/2024.6.JNS232810 PMID: 39454213












4. Multiple intravenous infusions versus a single infusion of mesenchymal stem cells in a rat model of cerebral ischemia
在大鼠脑缺血模型中,多次静脉输注与单次输注间充质干细胞


Researchers investigated whether multiple infusions of mesenchymal stem cells (MSCs) improved functional outcomes in acute cerebral ischemia in rats. They found that multiple MSC infusions significantly improved motor recovery, reduced ischemic volume, increased corpus callosum thickness, and increased the number of neural tracts compared with single standard or high-dose infusions. These findings suggest that multiple MSC infusions may be more effective for the treatment of acute cerebral ischemia via enhanced neuroprotection and induced neural plasticity.

研究人员研究了多次注射间充质干细胞(MSCs)是否能改善大鼠急性脑缺血的神经功能结局。他们发现,多次MSC注射显著改善了运动功能恢复,减少了缺血体积,增加了胼胝体厚度,并增加了神经纤维的数量。这些发现表明,多次MSC注射可能通过增强神经保护和诱导神经可塑性,对急性脑缺血的治疗更有效。

REF: Yokoyama T, Sasaki M, Nagahama H, et al. Multiple intravenous infusions versus a single infusion of mesenchymal stem cells in a rat model of cerebral ischemia. J Neurosurg. Published online October 25, 2024. doi:10.3171/2024.6.JNS241111 PMID: 39454218












5. Regional differences in reimbursement rates from Medicare, Medicaid, and FAIR Health across common procedures for neurological surgeons
神经外科医生常见程序中Medicare、Medicaid和FAIR Health的报销率的地区差异


The authors aimed to study regional differences in reimbursement rates across neurosurgical procedures and to compare Medicare, Medicaid, and usual, customary, and reasonable rates (UCRs) via FAIR Health rate estimates. This study found consistently lower reimbursement rates in Medicare and Medicaid when compared with the in-network and out-of-network FAIR Health estimates; while FAIR Health rates showed high variability across locales, Medicare and Medicaid did not significantly vary, despite being price-indexed for geography. This work reinforces concerns regarding Medicare and Medicaid reimbursement rates in neurosurgery.

作者旨在研究神经外科手术报销率的区域差异,并通过FAIR Health的估算率比较Medicare、Medicaid和通常、合理和习惯性(UCRs)率。这项研究发现,与FAIR Health的网络内和网络外估算率相比,Medicare和Medicaid的报销率始终较低;尽管FAIR Health的估算率在各地区存在较大差异,但Medicare和Medicaid的报销率并未出现显著变化,尽管它们已根据地理位置进行了价格调整。这项工作进一步强调了神经外科手术中Medicare和Medicaid报销率的问题。

REF: McGuire LS, Huntoon K, Gerald BM, et al. Regional differences in reimbursement rates from Medicare, Medicaid, and FAIR Health across common procedures for neurological surgeons. J Neurosurg. Published online October 25, 2024. doi:10.3171/2024.6.JNS24515 PMID: 39454216












6. Chordoma incidence, treatment, and survival in the 21st century: a population-based Ontario cohort study
21世纪脊索瘤发病率、治疗和生存率: 一项基于人群的安大略省队列研究


This population-based study quantified trends in the incidence, treatment, and survival of patients with chordoma in Ontario over a recent 17-year period. The average annual incidence was 12 cases per 10 million, with no significant change across the study period. The authors found evidence of increased treatment with radiotherapy or chemotherapy each year, with no significant changes in survival. Findings suggest an increased adoption of multidisciplinary cancer care for patients living with chordoma in Ontario.

这项基于人群的研究量化了最近17年安大略省脊索瘤患者的发病率、治疗和生存趋势。平均年发病率为每1000万人中有12例,在整个研究期间没有显著变化。作者发现每年增加放疗或化疗治疗的证据,生存率没有显著变化。研究结果表明,安大略省脊索瘤患者越来越多地采用多学科癌症护理。
REF: Shakil H, Malhotra AK, Essa A, et al. Chordoma incidence, treatment, and survival in the 21st century: a population-based Ontario cohort study. J Neurosurg. Published online October 18, 2024. doi:10.3171/2024.6.JNS24426 PMID: 39423422











7. Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study
无症状烟雾病的疾病进展、短暂性脑缺血发作和新生实质病变: AMORE研究的5年中期分析结果


Using the 5-year interim data of the first large-scale prospective multicenter study (AMORE), researchers aimed to clarify the 5-year risk of disease progression, transient ischemic attack (TIA), and de novo parenchymal lesions in asymptomatic moyamoya disease (MMD), and to identify risk predictors. Predictors of disease progression were younger age and hypercholesterolemia. Disease progression prior to TIA was a significant predictor for TIA. Microbleeds at enrollment were a significant predictor for de novo microbleeds. The authors report how asymptomatic MMD progresses prior to onset of cerebrovascular events and propose a strategy to manage asymptomatic MMD.

使用第一个大规模前瞻性多中心研究 (AMORE) 的5年中期数据,研究人员旨在阐明无症状烟雾病 (MMD) 中疾病进展、短暂性脑缺血发作 (TIA) 和新生实质病变的5年风险,并确定风险预测因子。疾病进展的预测因素是年龄较小和高胆固醇血症。TIA之前的疾病进展是TIA的重要预测因子。入组时的微出血是新生微出血的重要预测指标。作者报告了无症状性MMD在脑血管事件发生之前如何进展,并提出了管理无症状性MMD的策略。
REF: Kuroda S, Yamamoto S, Funaki T, et al. Disease progression, transient ischemic attack, and de novo parenchymal lesions in asymptomatic moyamoya disease: results of a 5-year interim analysis of the AMORE study. Journal of Neurosurgery. Published online October 18, 2024. doi:10.3171/2024.6.JNS24736











8. Electrocorticography and navigated transcranial magnetic stimulation–tailored supratotal resection for epileptogenic low-grade gliomas
皮质脑电图和导航经颅磁刺激定制的上切除术治疗癫痫源性低度胶质瘤


The authors evaluated electrocorticography and navigated transcranial magnetic stimulation-tailored supratotal resection (ETT-SpTR) for low-grade gliomas (LGGs) in controlling seizures and preserving neurological function. Their key finding was that ETT-SpTR significantly improved seizure outcomes, with 85.7% of patients in the ETT-SpTR group achieving Engel class IA outcomes. This study adds value by demonstrating the effectiveness of ETT-SpTR in improving epileptic outcomes while preserving neurological functions in LGG patients.

作者评估了低级别神经胶质瘤 (LGGs) 的脑电图和导航经颅磁刺激定制的上切除术 (ETT-SpTR) 在控制癫痫发作和保留神经功能方面的作用。他们的主要发现是ETT-SpTR显著改善了癫痫发作结局,ETT-SpTR组85.7%的患者达到Engel IA级结局。这项研究通过证明ETT-SpTR在改善LGG患者的癫痫结果同时保留神经功能的有效性来增加价值。
REF: Battista F, Muscas G, Parenti A, et al. Electrocorticography and navigated transcranial magnetic stimulation-tailored supratotal resection for epileptogenic low-grade gliomas. J Neurosurg. Published online October 18, 2024. doi:10.3171/2024.6.JNS24597 PMID: 39423425











长按并识别二维码即可查看更多期刊速览



声明:脑医汇旗下神外资讯、神介资讯、脑医咨询、AiBrain所发表内容之知识产权为脑医汇及主办方、原作者等相关权利人所有。未经许可,禁止进行转载、摘编、复制、裁切、录制等。经许可授权使用,亦须注明来源。欢迎转发、分享。

投稿/会议发布,请联系400-888-2526转3

脑医汇App(原神外资讯/神介资讯App)“话题圈子”重磅上线,这里有各种专业问题及权威解答,点击“阅读原文”抢先体验!

点分享

点收藏

点点赞

点在看

神外资讯
【脑医汇】品牌旗下新媒体,传播、分享神经外科领域的最新进展,为神经外科医生提供一个学术交流、业务交流的平台。
 最新文章